JUXTAPID Trademark

Trademark Overview

On Friday, December 14, 2012, a trademark application was filed for JUXTAPID with the United States Patent and Trademark Office. The USPTO has given the JUXTAPID trademark a serial number of 85802929. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 10, 2015. This trademark is owned by Aegerion Pharmaceuticals, Inc.. The JUXTAPID trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

PHARMACEUTICAL RESEARCH AND DEVELOPMENT IN THE FIELD OF CARDIOVASCULAR DISEASE, IN PARTICULAR, HYPERLIPIDEMIA
juxtapid

General Information

Serial Number85802929
Word MarkJUXTAPID
Filing DateFriday, December 14, 2012
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 10, 2015
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 14, 2013

Trademark Statements

Goods and ServicesPHARMACEUTICAL RESEARCH AND DEVELOPMENT IN THE FIELD OF CARDIOVASCULAR DISEASE, IN PARTICULAR, HYPERLIPIDEMIA

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, February 11, 2014
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAegerion Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142
Party NameAegerion Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events

Event DateEvent Description
Monday, August 10, 2015ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, August 10, 2015ABANDONMENT - NO USE STATEMENT FILED
Tuesday, January 13, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 9, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, January 12, 2015EXTENSION 3 GRANTED
Friday, January 9, 2015EXTENSION 3 FILED
Friday, January 9, 2015TEAS EXTENSION RECEIVED
Saturday, July 12, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 11, 2014EXTENSION 2 GRANTED
Wednesday, July 9, 2014EXTENSION 2 FILED
Wednesday, July 9, 2014TEAS EXTENSION RECEIVED
Wednesday, February 12, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 12, 2014CORRECTED NOA E-MAILED
Tuesday, February 11, 2014EXTENSION 1 GRANTED
Thursday, January 9, 2014EXTENSION 1 FILED
Tuesday, February 11, 2014DIVISIONAL PROCESSING COMPLETE
Tuesday, December 17, 2013DIVISIONAL REQUEST RECEIVED
Sunday, February 9, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, December 17, 2013TEAS REQUEST TO DIVIDE RECEIVED
Thursday, January 9, 2014TEAS EXTENSION RECEIVED
Tuesday, July 9, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 14, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 14, 2013PUBLISHED FOR OPPOSITION
Wednesday, April 24, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, April 6, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, April 3, 2013ASSIGNED TO LIE
Saturday, March 30, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, March 30, 2013ASSIGNED TO EXAMINER
Wednesday, January 2, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, December 18, 2012NEW APPLICATION ENTERED IN TRAM

Related Keywords

juxtapid disease particular hyperlipidemia cardiovascular field research development pharmaceutical